Harbert Fund Advisors’s Elevance Health ELV Stock Holding History

Harbert Fund Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,850	Closed	-$1.24M	–	27
2025 Q1	$1.24M	Buy	+2,850	New	+$1.14M	1.41%	28
2024 Q4	–	Sell	-5,250	Closed	-$2.73M	–	106
2024 Q3	$2.73M	Sell	5,250 -500	-9%	-$267K	1.62%	18
2024 Q2	$3.12M	Buy	5,750 +3,750	+188%	+$1.98M	2.21%	12
2024 Q1	$1.04M	Sell	2,000 -750	-27%	-$373K	0.71%	34
2023 Q4	$1.3M	Buy	+2,750	New	+$1.27M	0.89%	36
2023 Q2	–	Sell	-4,000	Closed	-$1.84M	–	46
2023 Q1	$1.84M	Buy	4,000 +1,350	+51%	+$642K	1.22%	40
2022 Q4	$1.36M	Sell	2,650 -3,550	-57%	-$1.8M	1.09%	27
2022 Q3	$2.82M	Buy	6,200 +950	+18%	+$455K	1.5%	18
2022 Q2	$2.53M	Buy	+5,250	New	+$2.6M	1.23%	24

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harbert Fund Advisors's ELV Position: Q2 2025 in Review

Harbert Fund Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,850 shares — an estimated $1.24M sold.

Harbert Fund Advisors first reported a position in ELV in Q2 2022 and held it in 9 quarters. The position peaked at $3.12M in Q2 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Harbert Fund Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Harbert Fund Advisors sold 2,850 Elevance Health shares in Q2 2025, an estimated $1.24M.
Harbert Fund Advisors first reported a position in Elevance Health in Q2 2022 and held it in 9 quarters.
Harbert Fund Advisors's Elevance Health position peaked at $3.12M in Q2 2024.
1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Harbert Fund Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.